Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06829953 · ClinicalTrials.gov registry record · NA
Get ActivE Study for At-risk Youth
A NA study of Anhedonia and Depression and Suicide Ideation, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 2
- Study locations
NCT06829953: Recruiting NA study of Anhedonia and Depression and Suicide Ideation, sponsored by University of Pittsburgh.
NCT06829953 is a NA study of Anhedonia and Depression and Suicide Ideation that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 75 participants, below the 107-participant average among 21 other Anhedonia trials with a reported enrollment target (30% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06829953, a NA study of Anhedonia and Depression and Suicide Ideation, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study will adapt and deploy a digital Behavioral Activation app with mobile sensing, supported by health coaches, that encourages youth to engage in positive activities. The study has the potential to offer a low-cost and scalable behavioral intervention that may decrease risk of suicide among at-risk youth. This research will examine specifically whether an intervention involving an app called Vira, combined with health coaching (GET ActivE) can improve enjoyment for teens coping with depression. Research participants will be randomly assigned to one of two study intervention. One study intervention involves a) downloading an app called Vira and engaging by responding to a daily question, and b) participating in a conversation via text, phone, or messages through an appt with a health coach. The health coach will use the Vira app and principles from evidence-based therapy and behavior change to provide users with insights to sustain well-being and better manage risk factors for suicidal thoughts and behaviors such as depressed mood and behavioral withdrawal. The second study intervention involves downloading an app called EARS and responding to a daily question.
Primary Outcome
The study will observe high GET ActivE intervention feasibility (50% of eligible youth approached will enroll; completion \>50%; attrition \<20%)
Conditions Studied
Interventions
- BEHAVIORAL Treatment As Usual
- BEHAVIORAL GET ActivE
Study Locations (2)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2025-03-27 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06829953 shows while recruiting
NCT06829953 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 107-participant average among 21 other Anhedonia trials with a reported enrollment target (30% lower).
The record links to 2 conditions, with Anhedonia appearing as the primary indexed condition, and to 2 interventions - of which Treatment As Usual is the first listed.
NCT06829953 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06829953 about?
NCT06829953 is a clinical study titled "Get ActivE Study for At-risk Youth". The study will adapt and deploy a digital Behavioral Activation app with mobile sensing, supported by health coaches, that encourages youth to engage in positive activities. The study has the potential to offer a low-cost and scalable behavioral intervention that may decrease risk of suicide among a...
What is the current status of trial NCT06829953?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2025-03-27. Estimated completion is 2026-12-31.
What conditions does trial NCT06829953 study?
This clinical trial studies the following conditions: Anhedonia, Depression and Suicide Ideation.
What interventions are being tested in trial NCT06829953?
The interventions under investigation include: Treatment As Usual (BEHAVIORAL), GET ActivE (BEHAVIORAL).
Who is sponsoring clinical trial NCT06829953?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06829953 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anhedonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06829953's enrollment target sits among peer trials
75 12th of 21 higher than 10 of 21 other Anhedonia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anhedonia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression
RECRUITING · NA
-
Reward Processing and Exposure Therapy for Social Anxiety Disorder
RECRUITING · NA
-
Psychotherapy Effects on Reward Processing in PTSD
RECRUITING · NA
-
Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression
RECRUITING · NA
-
Geolocation Positional System (GPS) Experience
RECRUITING · NA
-
Stress Trajectories and Anhedonia in Adolescence Research Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI